- Home
- DTCK vs LPCN Comparison
DTCK vs LPCN Comparison
Compare DTCK & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- LPCN
- Stock Information
- Founded
- DTCK 1999
- LPCN 1997
- Country
- DTCK Singapore
- LPCN United States
- Employees
- DTCK N/A
- LPCN N/A
- Industry
- DTCK Farming/Seeds/Milling
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- DTCK Industrials
- LPCN Health Care
- Exchange
- DTCK Nasdaq
- LPCN Nasdaq
- Market Cap
- DTCK 26.5M
- LPCN 27.1M
- IPO Year
- DTCK 2023
- LPCN N/A
- Fundamental
- Price
- DTCK $1.08
- LPCN $4.62
- Analyst Decision
- DTCK
- LPCN Strong Buy
- Analyst Count
- DTCK 0
- LPCN 1
- Target Price
- DTCK N/A
- LPCN $10.00
- AVG Volume (30 Days)
- DTCK 91.4K
- LPCN 32.3K
- Earning Date
- DTCK 11-13-2024
- LPCN 03-06-2025
- Dividend Yield
- DTCK N/A
- LPCN N/A
- EPS Growth
- DTCK N/A
- LPCN N/A
- EPS
- DTCK 0.02
- LPCN N/A
- Revenue
- DTCK $159,836,000.00
- LPCN $7,922,926.00
- Revenue This Year
- DTCK N/A
- LPCN N/A
- Revenue Next Year
- DTCK N/A
- LPCN N/A
- P/E Ratio
- DTCK $59.03
- LPCN N/A
- Revenue Growth
- DTCK N/A
- LPCN N/A
- 52 Week Low
- DTCK $0.80
- LPCN $3.20
- 52 Week High
- DTCK $1.75
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- DTCK 50.49
- LPCN 43.02
- Support Level
- DTCK $1.04
- LPCN $4.25
- Resistance Level
- DTCK $1.17
- LPCN $4.73
- Average True Range (ATR)
- DTCK 0.09
- LPCN 0.33
- MACD
- DTCK -0.00
- LPCN -0.04
- Stochastic Oscillator
- DTCK 59.14
- LPCN 20.80
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.